MENLO PARK, Calif.–(BUSINESS WIRE)– #SeriesA–Sudo Biosciences Raises $37M Series A Financing to Advance Precision TYK2 Therapeutics
News Ticker
- [ September 27, 2023 ] Curio Wellness Appoints Dr. David “Dedi” Meiri to its Scientific Advisory Board News
- [ September 27, 2023 ] Gilead stops another CD47 study, this time in acute myeloid leukemia News
- [ September 27, 2023 ] Atropos Health Announces Agreement to Accelerate Real World Evidence Generation News
- [ September 27, 2023 ] FDA Grants Breakthrough Device Designation to Gravitas Medical for Neonatal Patients Requiring Enteral Feeding News
- [ September 27, 2023 ] InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO News
Copyright © 2023 Biotech Networks, LLC
